Advertisement

Picture Berlin Partner Top News EIC Accelerator Noah Labs MyoPax 650x100px
Organisation › Details

Evonetix Ltd.

Evonetix is reimagining biology by developing a radically different approach to gene synthesis – a highly parallel desktop platform to synthesise DNA at unprecedented accuracy and scale. The technology builds on scalability and density from the semiconductor industry to deliver a step-change in performance for the production of DNA. The company’s platform will place DNA synthesis in the hands of every researcher and change how DNA is accessed, made and used. This new paradigm in gene synthesis will facilitate and enable the rapidly growing field of synthetic biology. The proprietary Evonetix approach utilises a silicon chip, made by MEMS processing, that integrates physics with biology, and controls the synthesis of DNA at many thousands of independently controlled reaction sites or ‘pixels’ on the chip surface in a highly parallel fashion. The approach is compatible with both chemical and enzymatic DNA synthesis. Following synthesis, strands are assembled on-chip into double-stranded DNA in a process that identifies and removes errors, providing accuracy that is several orders of magnitude better than the conventional approach. The Evonetix DNA writer will be a desktop device, available to every researcher, and providing scalable, accurate DNA synthesis to enable biological systems to be engineered with unprecedented accuracy and scale – this is third-generation DNA synthesis. *

 

Period Start 2016-01-01 established
Product Industry synthetic biotechnology
Persons Person McCracken, Colin (Evonetix 202206– CEO before Fluidigm + Thermo Fisher + Life Technologies + Qiagen)
  Person 2 Beastall, Paul (Evonetix 202206 Board Chair)
     
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street Norman Way
Coldham’s Business Park, 9a
  City CB1 3LH Cambridge, Cambridgeshire
  Tel +44-1223-930300
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Evonetix Ltd.. (6/13/22). "Press Release: Colin McCracken Joins Evonetix as Chief Executive Officer".
     
   
Record changed: 2025-03-16

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Evonetix Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x300px




» top